Compare Medpace Holdings Inc (MEDP) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Twilio Inc — how do they compare? Medpace Holdings Inc trades at $534.03 (market cap $15.08B), while Twilio Inc trades at $195.21 (market cap $31.15B). The key difference: Twilio Inc is far larger — about 2.1× Medpace Holdings Inc's market cap. Which is the better fit depends on your goals.
| MEDP | TWLO | |
|---|---|---|
Market Cap | $15.08B | $31.15B |
Sector | Technology | Technology |
52-Week High | $620.59 | $236.64 |
52-Week Low | $308.88 | $92.44 |
Enterprise Value | $14.55B | $29.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Twilio (TWLO) trades at $208.56, up 0.86% with a bullish technical outlook. The stock has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 6, 2026. Revenue grew to $5.07B in 2025, and net income turned positive at $33.83M. Analyst sentiment is strongly positive with a consensus price target of $223.00. Operating cash flow improved significantly to $1.00B in 2025, indicating strengthening financial health.
The outlook for Twilio is optimistic due to consistent earnings beats and robust revenue growth, though high valuation multiples pose risks. Key opportunities include AI-driven communication tools and margin expansion under new leadership. Risks include intense competition and execution challenges in sustaining profitability. Investors should monitor Q2 2026 earnings for continued momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
